Integrating the creation or use of new and developing technologies, intellectual property or data into either the organisation itself or as an aspect of its business strategy

Experienced in pulling the commercial levers

Our deep experience with technology, biotech and IP based companies in various legal and management capacities means we genuinely get what you need to do to advance your business.

Like all other law firms we draft contracts, policies and T&Cs – but ours are informed by an in-depth knowledge of law and business practices in the markets you work in, including life sciences, software, online commerce and logistics.

In life sciences, we understand that when you are licensing, partnering or outsourcing you need lawyers that understand the jargon, are clear in identifying the key typical similarities and differences in such agreements and appreciate the relevant regulatory and commercial environment.

In cloud computing we are familiar with SaaS, EaaS and documenting cloud based solutions. Whatever it is, there is a good chance we have done it before and can help you.

Concise sector focused advice is often delivered by email, but with the underlying assurance that you are dealing with deeply experienced professionals. Negotiations are facilitated in a calm and professional manner. Documentation is provided in plain English. And our background as litigators ensures every contract contains what it needs to if relationships in a deal turn sour.

Over time, we have acted for both sides in numerous kinds of critical matters so we can anticipate potential points of tension. We also help manage the day-to-day issues and risks. We offer solutions that we know work in practice.

What can we do for you?

Like most M&A lawyers, we offer technical competence in M&A. We combine this with decades of experience on-the-tools, gained working inside and acting for mid-market tech companies (listed, unlisted and owner operated), giving us an ability to anticipate menaces to navigation and guide you through the options on the path to closing, as we have for others, many, many times previously.